Universtity of Texas Southwestern Medical Center

Dallas, Texas 75390

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Previously Treated CD20 B-cell Malignancies Clinical Trial
Phase I Study of Subcutaneous Ocaratuzumab in Patients With Previously Treated CD20+ B-Cell Malignancies
Status: Upcoming, Phase I
Updated: 2/28/2014
Universtity of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials